Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GuardianCath
- Development stage
- Unknown
- Lead developer
- Children's Hospital Zagreb
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
GuardianCath is an antiseptic-coated intermittent hydrophilic urinary catheter developed for the prevention of catheter-associated urinary tract infections (CAUTI), specifically in pediatric patients with neurogenic bladder. The catheter is coated with octenidine chloride (octenidine dihydrochloride), a bispyridine antiseptic with broad-spectrum antimicrobial activity. It works by creating an antimicrobial layer on the catheter surface that inhibits bacterial adhesion and the formation of biofilms by common uropathogens such as *Escherichia coli*, *Pseudomonas aeruginosa*, and *Proteus mirabilis*. Children's Hospital Zagreb has conducted clinical trials (NCT02697162) to evaluate its efficacy and feasibility in children requiring clean intermittent catheterization.
- Brand names
- GuardianCath
- Other names
- octenidine chloride-coated intermittent hydrophilic urinary catheteroctenidine dihydrochlorideoctenidine chloride
Beyond the preview
Go deeper on GuardianCath.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GuardianCath.